Shilp Gravures Limited
NSE: SHILGRAVQ | Information Technology
Market Fundamentals
Stock Intelligence & News
Sai Silks (Kalamandir) Limited
Sai Silks (Kalamandir) Limited has informed the Exchange regarding Appointment of Ms Shilpa Kotagiri as Company Secretary & Compliance Officer of the company w.e.f. October 01, 2026. |SUBJECT: Appointment
Read Full Analysis →Sai Silks (Kalamandir) Ltd (543989)
Ms. Shilpa Kotagiri a member of ICSI holding membership no. A23208 was appointed as Company Secretary and Compliance Officer of the Company by the Board of Directors in their meeting held on 29.09.2026
Read Full Analysis →Shilpa Medicare's 238% Rally Faces An Earnings Test
Shilpa Medicare is scaling formulations, biologics, peptides and CDMO alongside its core API business, with Q1FY27 revenue and profit reaching record levels. After a 238% gain in 2026, the focus is shifting to whether its pipeline and new capacity can sustain earnings growth.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Shilpa Medicare Limited
Shilpa Medicare Limited has informed the Exchange about Assignment of ESG Rating by CRISIL ESG Ratings. |SUBJECT: General Updates
Read Full Analysis →Shilpa Medicare Ltd (530549)
Assignment of ESG Ratings by CRISIL ESG Ratings
Read Full Analysis →Upto 360% Jump In One Year: Why Small-Cap Pharma Stocks Like Bliss GVS, Shilpa Medicare, Others Are Beating Large Caps?
Large-cap pharma stocks have delivered more moderate returns.
Read Full Analysis →Shilpa Medicare Limited
Shilpa Medicare Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Shilpa Medicare Ltd (530549)
USFDA Inspection of Shilpa Medicare Limited at Unit VII, Analytical Services Division, Hyderabad.
Read Full Analysis →Shilpa Medicare Limited
Shilpa Medicare Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 11, 2026 |SUBJECT: Shareholders meeting
Read Full Analysis →Shilpa Medicare Limited
Shilpa Medicare Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "Shilpa Medicare's Novel Complex Injectable OERIS (Ondansetron Extended-Release Injection, 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing authorization.". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when SHILGRAVQ breaks news
Join investors who track Shilp Gravures Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SHILGRAVQ?
SHILGRAVQ is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Shilp Gravures Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SHILGRAVQ to your custom watchlist.